Two years ago, Jennifer Kirtley looked down at the scale and saw 328 pounds. Today, she’s looking in the mirror at a size 6.

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

Kuopio, Finland, March 19, 2026 (GLOBE NEWSWIRE) -- GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric ...

Mounjaro generated $8.66 billion in sales in the first quarter.

Youth with obesity but without type 2 diabetes were 31% less likely to develop type 2 diabetes if they were prescribed a glucagon-like peptide 1 (GLP-1) receptor agonist medication instead of an older ...

Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a ...

Please provide your email address to receive an email when new articles are posted on . Treat obesity as the root cause of diabetes. By integrating obesity care into diabetes prevention programs, ...

Please provide your email address to receive an email when new articles are posted on . The American Diabetes Association Scientific Sessions featured symposia on novel treatments for diabetes and ...

About a third of us in Missouri and Kansas are obese, but getting a prescription for one of these powerful drugs online comes ...

Americans' voracious appetite for GLP-1 weight loss drugs has the nation on pace to spend more than $1 trillion on ...

SAN FRANCISCO—Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes, according to a new study being presented Monday ...

Ozempic is now available in pill form for people with type 2 diabetes. Novo Nordisk says the oral GLP-1's new lower-dose ...